Connecticut PAMA 2026 Reporting: What Hospital Outreach Labs Must Submit Before July 31, 2026

Connecticut hospital outreach laboratories have an important Medicare reporting deadline in 2026. Under the updated Clinical Laboratory Fee Schedule (CLFS) reporting schedule, applicable laboratories must submit required private payer data to CMS between May 1 and July 31, 2026.

For hospital outreach laboratories, determining whether the laboratory qualifies as an applicable laboratory is especially important because CMS uses a different billing pathway when the laboratory submits Medicare claims through the hospital's 14X Type of Bill. The reporting process also requires laboratories to organize applicable HCPCS codes, private payer rates, and test volume information from the designated data collection period.

The 2026 reporting period is based on data collected from January 1 through June 30, 2025.

What PAMA Reporting Means for Connecticut Hospital Outreach Labs

The Protecting Access to Medicare Act established the framework under which CMS collects private payer information to calculate Medicare payment rates for many clinical diagnostic laboratory tests.

CMS generally uses the weighted median of private payer rates to establish CLFS payment amounts for applicable laboratory tests. Because those calculations depend on information submitted by laboratories, accurate reporting can affect future Medicare payment rates.

The 2026 reporting cycle has an important timing change. Following the Consolidated Appropriations Act, 2026, CMS moved the reporting window to May 1 through July 31, 2026, using a data collection period of January 1 through June 30, 2025. CMS also confirmed that there is no CLFS phase-in reduction in 2026. Beginning in 2027 through 2029, applicable payment amounts may not be reduced by more than 15% per year compared with the preceding year's payment amount.

For Connecticut hospital outreach laboratories, the immediate priority is making sure the correct reporting entity, revenue data, payer information, and test-level data are identified before submission.

How a Hospital Outreach Laboratory Determines Applicable Status

Not every hospital laboratory automatically has to report PAMA data.

CMS defines a hospital outreach laboratory as a hospital-based laboratory that furnishes laboratory tests to patients other than admitted inpatients or registered outpatients of the hospital. For applicable-status purposes, CMS allows hospital outreach laboratories to use Medicare claims submitted under the 14X Type of Bill.

The first consideration is whether the laboratory is CLIA certified, including an applicable CLIA certificate of waiver. The laboratory must then determine how its Medicare Part B services are billed.

If the hospital outreach laboratory bills under the 14X Type of Bill, CMS applies the applicable-laboratory tests using the laboratory's Medicare revenue associated with that billing arrangement.

The laboratory generally must meet two financial tests. Its Medicare CLFS and Physician Fee Schedule revenue must represent more than 50% of its total Medicare revenue during the applicable data collection period, and its Medicare CLFS revenue must reach at least $12,500.

This distinction is particularly important for hospital-based laboratories because the result can differ depending on whether outreach services are billed through the hospital's NPI or through another billing structure.

What Data Must Be Reported?

Once a Connecticut hospital outreach laboratory determines that it is an applicable laboratory, the next step is gathering the information CMS requires.

The reporting process centers on laboratory test HCPCS codes, associated private payer rates, and volume data. CMS instructs applicable laboratories to report information based on final paid claims from the January 1 through June 30, 2025 data collection period.

Private payers can include commercial health insurance issuers, group health plans, Medicare Advantage plans, and Medicaid Managed Care Organizations. The relevant payment information needs to reflect the final amount paid for the laboratory service rather than an initial payment that was later changed during the applicable period.

For an outreach laboratory, this means the data review should go beyond simply exporting every laboratory claim. The billing team needs to determine which claims fall within the reporting requirements and whether the payment information represents the final applicable amount.

Why Final Paid Claims Matter

CMS defines a final paid claim as the final amount paid by a private payer for a laboratory test during the data collection period.

If a private payer initially pays a claim and later changes the payment amount through a post-payment adjustment during the data collection period, the final payment amount is used for reporting purposes. However, CMS provides specific treatment for claims corrected after the data collection period, so laboratories should review the CMS guidance rather than applying one rule to every adjusted claim.

This makes payment reconciliation an important part of the reporting process.

How Hospital Outreach Labs Should Organize Their Data

Connecticut hospital outreach laboratories can reduce reporting problems by separating their data into the categories CMS requires.

The first layer is the applicable HCPCS code. The second is the private payer rate associated with that code and service. The third is the volume of services represented by the applicable paid claims.

The laboratory should also maintain a clear connection between its reporting entity, tax identification information, NPI structure, and applicable outreach billing records.

CMS explains that the TIN-level entity serves as the reporting entity and must report applicable information for its component NPI-level entities that meet the definition of an applicable laboratory.

This can become important for hospital systems with multiple laboratory locations, billing NPIs, or outreach operations. Data should be consolidated according to CMS reporting requirements rather than simply combining every laboratory record into one file.

The Role of Billing Accuracy in PAMA Reporting

PAMA reporting is based on historical payment data, so errors in the underlying billing records can create problems during the reporting process.

Accurate lab billing and coding services can help hospital outreach laboratories maintain cleaner HCPCS-level records, reconcile payer payments, identify adjustments, and separate applicable outreach revenue from other hospital revenue.

This does not mean billing teams should alter historical data to produce a preferred result. The purpose of the review is to ensure that the information being reported accurately reflects the final paid claims and the applicable CMS reporting rules.

A strong reconciliation process can also identify differences between billed amounts, allowed amounts, contractual adjustments, and actual payer payments before the laboratory submits its information.

What Connecticut Labs Need to Complete Before July 31

The July 31 deadline applies to the 2026 PAMA data reporting period. CMS specifically instructed applicable independent, physician office, and hospital outreach laboratories to report the required information by that date.

For Connecticut hospital outreach laboratories, preparation should include confirming applicable status, validating the 14X Type of Bill or applicable NPI billing structure, reviewing the Medicare revenue thresholds, and organizing the private payer data from the 2025 collection period.

The laboratory also needs to use CMS's current reporting resources, including the applicable HCPCS code file and the 2026 CLFS Data Reporting Template. CMS updated the applicable HCPCS file in February 2026 and the reporting template in March 2026.

The reporting entity must also complete the appropriate registration and certification steps within CMS's CLFS Data Collection System.

Why 2026 Reporting Matters Beyond the Deadline

The July 31 submission is not simply an administrative requirement. PAMA data contributes to the payment methodology used for clinical laboratory services under the CLFS.

CMS has already published preliminary CY 2027 CLFS information based on the current reporting cycle. The agency reported preliminary changes across laboratory test codes, demonstrating why accurate private payer data remains important to the future Medicare payment structure.

For Connecticut hospital outreach laboratories, accurate reporting therefore has both an immediate compliance purpose and a longer-term reimbursement significance.

The laboratory should retain supporting records that explain how the reported rates and volumes were calculated. This makes it easier to validate the submission and respond to questions if the underlying information needs to be reviewed later.

Preparing for Future PAMA Reporting Cycles

Although the current reporting deadline is July 31, 2026, hospital outreach laboratories can use the experience to improve future data collection.

Maintaining consistent payer mapping, HCPCS-level payment records, final payment information, and outreach-specific revenue reporting throughout the year can make future PAMA preparation less dependent on a last-minute data pull.

The 2026 reporting cycle is particularly important because the next CLFS payment framework begins in 2027. CMS currently states that applicable payment amounts may not be reduced by more than 15% per year from 2027 through 2029.

For Connecticut hospital outreach laboratories, accurate reporting and reimbursement analysis should therefore be treated as part of ongoing revenue-cycle management rather than as a one-time July deadline.

Conclusion

Connecticut hospital outreach laboratories that meet CMS's definition of an applicable laboratory must pay close attention to the 2026 PAMA reporting requirements. The reporting period runs through July 31, 2026, and the underlying data comes from final paid claims collected between January 1 and June 30, 2025.

The most important areas are applicable-laboratory status, 14X billing information, Medicare revenue thresholds, applicable HCPCS codes, private payer rates, and service volumes.

By validating these records before submission and maintaining clear supporting documentation, hospital outreach laboratories can make their PAMA reporting process more accurate and easier to manage. The same data can also provide useful insight into how future CLFS payment changes may affect laboratory reimbursement.